234 related articles for article (PubMed ID: 19229865)
1. The role of the disintegrin metalloproteinase ADAM15 in prostate cancer progression.
Lucas N; Day ML
J Cell Biochem; 2009 Apr; 106(6):967-74. PubMed ID: 19229865
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the catalytic activity of the membrane-anchored metalloproteinase ADAM15 in cell-based assays.
Maretzky T; Yang G; Ouerfelli O; Overall CM; Worpenberg S; Hassiepen U; Eder J; Blobel CP
Biochem J; 2009 Apr; 420(1):105-13. PubMed ID: 19207106
[TBL] [Abstract][Full Text] [Related]
3. ADAM 15 is an adhesion receptor for platelet GPIIb-IIIa and induces platelet activation.
Langer H; May AE; Bültmann A; Gawaz M
Thromb Haemost; 2005 Sep; 94(3):555-61. PubMed ID: 16268472
[TBL] [Abstract][Full Text] [Related]
4. ADAM15 suppresses cell motility by driving integrin alpha5beta1 cell surface expression via Erk inactivation.
Chen Q; Meng LH; Zhu CH; Lin LP; Lu H; Ding J
Int J Biochem Cell Biol; 2008; 40(10):2164-73. PubMed ID: 18387333
[TBL] [Abstract][Full Text] [Related]
5. ADAM15 expression is downregulated in melanoma metastasis compared to primary melanoma.
Ungerer C; Doberstein K; Bürger C; Hardt K; Boehncke WH; Böhm B; Pfeilschifter J; Dummer R; Mihic-Probst D; Gutwein P
Biochem Biophys Res Commun; 2010 Oct; 401(3):363-9. PubMed ID: 20851104
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the microenvironment and adhesion of cancer cells by ADAMs (a disintegrin and metalloproteinase).
Okada Y
Verh Dtsch Ges Pathol; 2007; 91():29-38. PubMed ID: 18314593
[TBL] [Abstract][Full Text] [Related]
7. Homeostatic effects of the metalloproteinase disintegrin ADAM15 in degenerative cartilage remodeling.
Böhm BB; Aigner T; Roy B; Brodie TA; Blobel CP; Burkhardt H
Arthritis Rheum; 2005 Apr; 52(4):1100-9. PubMed ID: 15818704
[TBL] [Abstract][Full Text] [Related]
8. Presence, processing, and localization of mouse ADAM15 during sperm maturation and the role of its disintegrin domain during sperm-egg binding.
Pastén-Hidalgo K; Hernández-Rivas R; Roa-Espitia AL; Sánchez-Gutiérrez M; Martínez-Pérez F; Monrroy AO; Hernández-González EO; Mújica A
Reproduction; 2008 Jul; 136(1):41-51. PubMed ID: 18390692
[TBL] [Abstract][Full Text] [Related]
9. Exosome release of ADAM15 and the functional implications of human macrophage-derived ADAM15 exosomes.
Lee HD; Koo BH; Kim YH; Jeon OH; Kim DS
FASEB J; 2012 Jul; 26(7):3084-95. PubMed ID: 22505472
[TBL] [Abstract][Full Text] [Related]
10. ADAM15 supports prostate cancer metastasis by modulating tumor cell-endothelial cell interaction.
Najy AJ; Day KC; Day ML
Cancer Res; 2008 Feb; 68(4):1092-9. PubMed ID: 18281484
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of the A Disintegrin and Metalloproteinase ADAM15 is linked to a Small but Highly Aggressive Subset of Prostate Cancers.
Burdelski C; Fitzner M; Hube-Magg C; Kluth M; Heumann A; Simon R; Krech T; Clauditz T; Büscheck F; Steurer S; Wittmer C; Hinsch A; Luebke AM; Jacobsen F; Minner S; Tsourlakis MC; Beyer B; Steuber T; Thederan I; Sauter G; Izbicki J; Schlomm T; Wilczak W
Neoplasia; 2017 Apr; 19(4):279-287. PubMed ID: 28282546
[TBL] [Abstract][Full Text] [Related]
12. ADAM15 Is Functionally Associated with the Metastatic Progression of Human Bladder Cancer.
Lorenzatti Hiles G; Bucheit A; Rubin JR; Hayward A; Cates AL; Day KC; El-Sawy L; Kunju LP; Daignault S; Lee CT; Liebert M; Hussain M; Day ML
PLoS One; 2016; 11(3):e0150138. PubMed ID: 26930657
[TBL] [Abstract][Full Text] [Related]
13. Screening cellular proteins involved in the anti-proliferative effect of the ADAM15 disintegrin domain in murine melanoma cells.
Wu J; Zhang L; Ma X; Zhang X; Jin J
Oncol Rep; 2008 Sep; 20(3):669-75. PubMed ID: 18695922
[TBL] [Abstract][Full Text] [Related]
14. Cell adhesion-induced transient interaction of ADAM15 with poly(A) binding protein at the cell membrane colocalizes with mRNA translation.
Böhm BB; Fehrl Y; Janczi T; Schneider N; Burkhardt H
PLoS One; 2018; 13(9):e0203847. PubMed ID: 30265671
[TBL] [Abstract][Full Text] [Related]
15. Alternative splicing of ADAM15 regulates its interactions with cellular SH3 proteins.
Kleino I; Ortiz RM; Yritys M; Huovila AP; Saksela K
J Cell Biochem; 2009 Nov; 108(4):877-85. PubMed ID: 19718658
[TBL] [Abstract][Full Text] [Related]
16. Breaking up the tie: disintegrin-like metalloproteinases as regulators of cell migration in inflammation and invasion.
Reiss K; Ludwig A; Saftig P
Pharmacol Ther; 2006 Sep; 111(3):985-1006. PubMed ID: 16626807
[TBL] [Abstract][Full Text] [Related]
17. Signal transduction by focal adhesion kinase in cancer.
Zhao J; Guan JL
Cancer Metastasis Rev; 2009 Jun; 28(1-2):35-49. PubMed ID: 19169797
[TBL] [Abstract][Full Text] [Related]
18. ADAM15 disintegrin is associated with aggressive prostate and breast cancer disease.
Kuefer R; Day KC; Kleer CG; Sabel MS; Hofer MD; Varambally S; Zorn CS; Chinnaiyan AM; Rubin MA; Day ML
Neoplasia; 2006 Apr; 8(4):319-29. PubMed ID: 16756724
[TBL] [Abstract][Full Text] [Related]
19. ADAM15 to α5β1 integrin switch in colon carcinoma cells: a late event in cancer progression associated with tumor dedifferentiation and poor prognosis.
Toquet C; Colson A; Jarry A; Bezieau S; Volteau C; Boisseau P; Merlin D; Laboisse CL; Mosnier JF
Int J Cancer; 2012 Jan; 130(2):278-87. PubMed ID: 21190186
[TBL] [Abstract][Full Text] [Related]
20. Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead.
van Hinsbergh VW; Koolwijk P
Cardiovasc Res; 2008 May; 78(2):203-12. PubMed ID: 18079100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
